HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations.

Abstract
We have developed a new liquid material for embolisation of arteriovenous malformations: a mixture of methyl and butyl methacrylate, plus dimethylaminoethyl methacrylate copolymer (Eudragit-E) in a solvent consisting of ethanol and iopamidol. Upon contact with aqueous substances, Eudragit-E precipitates rapidly and forms a soft elastic sponge within 3 s, as the ethanol diffuses. In blood, the positively charged Eudragit-E aggregates the negatively charged blood elements. Transcatheter embolisation of 4 canine and 52 rat renal arteries was feasible. Histological studies revealed no acute inflammatory reaction within 1 week, but mild to moderate reactions in the subacute and chronic stages. No recanalisation was seen. Because of its unique properties and excellent thrombogenicity the Eudragit-E, mixture seems a promising embolic material.
AuthorsK Yamashita, W Taki, H Iwata, H Kikuchi
JournalNeuroradiology (Neuroradiology) Vol. 38 Suppl 1 Pg. S151-6 (May 1996) ISSN: 0028-3940 [Print] Germany
PMID8811703 (Publication Type: Journal Article)
Chemical References
  • Biocompatible Materials
  • Methacrylates
  • Methylmethacrylates
  • Eudragit-E
Topics
  • Analysis of Variance
  • Animals
  • Arteriovenous Malformations (therapy)
  • Biocompatible Materials
  • Catheterization, Peripheral (methods)
  • Dogs
  • Embolization, Therapeutic (methods)
  • Endothelium, Vascular (drug effects)
  • Follow-Up Studies
  • Inflammation (etiology)
  • Infusions, Intra-Arterial
  • Materials Testing
  • Methacrylates (administration & dosage, adverse effects, chemistry)
  • Methylmethacrylates
  • Radiography
  • Rats
  • Rats, Wistar
  • Renal Artery (diagnostic imaging)
  • Viscosity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: